title: Ivabradine is cost-effective in the treatment of chronic heart failure.
authors.affiliation: Department of Applied Health Research, University College London, London, UK.
authors.forename: Stephen
authors.initials: S
authors.lastname: Morris
authors.affiliation: Research Department of Primary Care & Population Health, University College London, London, UK.
authors.forename: Rachael
authors.initials: R
authors.lastname: Hunter
mesh_terms: D000889:Anti-Arrhythmia Agents / Q000191:economics* / Q000627:therapeutic use*; D001552:Benzazepines / Q000191:economics* / Q000627:therapeutic use*; D016527:Drug Costs; D006333:Heart Failure / Q000188:drug therapy* / Q000191:economics*; D006801:Humans; D000077550:Ivabradine; D013222:State Medicine / Q000191:economics*
chemical_list: D000889:Anti-Arrhythmia Agents; D001552:Benzazepines; D000077550:Ivabradine
keywords: Quality of Care and Outcomes